We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00455260
Recruitment Status : Completed
First Posted : April 3, 2007
Last Update Posted : September 2, 2013
Teva Pharmaceutical Industries
TransPharma Medical
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Neuroscience, Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2007
  Study Completion Date : No date given